Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-12-000910
Filing Date
2012-02-14
Accepted
2012-02-14 17:20:26
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 c68492_10q.htm 10-Q 297006
2 c68492_ex31-1.htm EX-31.1 8844
3 c68492_ex31-2.htm EX-31.2 8647
4 c68492_ex32-1.htm EX-32.1 3442
5 c68492_ex32-2.htm EX-32.2 3467
  Complete submission text file 0000930413-12-000910.txt   1807321

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ibio-20111231.xml EX-101.INS 323057
7 ibio-20111231.xsd EX-101.SCH 12107
8 XBRL CALCULATION FILE ibio-20111231_cal.xml EX-101.CAL 19116
9 XBRL DEFINITION FILE ibio-20111231_def.xml EX-101.DEF 55462
10 XBRL LABEL FILE ibio-20111231_lab.xml EX-101.LAB 80260
11 XBRL PRESENTATION FILE ibio-20111231_pre.xml EX-101.PRE 63439
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 12612742
SIC: 2834 Pharmaceutical Preparations